{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:39:37Z","timestamp":1761561577748,"version":"build-2065373602"},"reference-count":154,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":1841,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1477-2574.2011.00380.x","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T05:36:51Z","timestamp":1319002611000},"page":"846-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic syndrome and hepatic resection: improving outcome"],"prefix":"10.1016","volume":"13","author":[{"given":"Shefali","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherag","family":"Daruwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. American Heart Association; National Heart, Lung, and Blood Institute","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/ALN.0b013e3181eff32e","article-title":"Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery","volume":"113","author":"Glance","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/DCR.0b013e3181bdbc32","article-title":"Impact of metabolic syndrome on the short-term outcomes of colorectal cancer surgery","volume":"53","author":"Lohsiriwat","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2007.04.075","article-title":"Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery","volume":"50","author":"Echahidi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-09-0842","article-title":"Metabolic syndrome as a risk factor for postoperative kidney injury after off-pump coronary artery bypass surgery","volume":"74","author":"Hong","year":"2010","journal-title":"Circ J"},{"issue":"11","key":"10.1111\/j.1477-2574.2011.00380.x_bb0035","first-page":"I213","article-title":"Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery","volume":"116","author":"Echahidi","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0040","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jvs.2008.12.011","article-title":"Metabolic syndrome: a predictor of adverse outcomes after carotid revascularization","volume":"49","author":"Protack","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0045","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.STR.0000169945.75911.33","article-title":"Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease","volume":"36","author":"Koren-Morag","year":"2005","journal-title":"Stroke"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.thromres.2010.12.006","article-title":"Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: a cross sectional study","volume":"127","author":"Dentali","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0075","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/j.1572-0241.2006.00719.x","article-title":"Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD","volume":"101","author":"Kang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000658-200210000-00001","article-title":"Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade","volume":"236","author":"Jarnagin","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","article-title":"Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection","volume":"191","author":"Belghiti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"de Meijer","year":"2010","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.sla.0000251747.80025.b7","article-title":"Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study","volume":"245","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/bjs.5820","article-title":"Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis","volume":"94","author":"Gomez","year":"2007","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(98)80025-5","article-title":"Hepatic steatosis as a potential risk factor for major hepatic resection","volume":"2","author":"Behrns","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0120","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0130","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0135","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. NASH CRN","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0140","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.tp.0000166009.77444.f3","article-title":"Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation","volume":"80","author":"Nakamuta","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0145","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0150","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0155","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0160","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1111\/j.1477-2574.2011.00380.x_bb0165","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2013 the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0175","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"3","key":"10.1111\/j.1477-2574.2011.00380.x_bb0185","first-page":"E286","article-title":"Relationship between degree of obesity and in vivo insulin action in man","volume":"248","author":"Bogardus","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.ATV.0000208363.85388.8f","article-title":"Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men","volume":"26","author":"Matsushita","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0140-6736(02)07281-1","article-title":"Resistin, central obesity, and type 2 diabetes","volume":"359","author":"McTernan","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0200","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0210","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0140-6736(03)14727-7","article-title":"Adiponectin: linking the fat cell to insulin sensitivity","volume":"362","author":"Goldfine","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0220","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0225","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(05)70804-7","article-title":"Endothelial inflammation in insulin resistance","volume":"365","author":"Sj\u00f6holm","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000080884.27358.49","article-title":"Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Study of Health Assessment and Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators","volume":"108","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0235","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/diacare.28.9.2211","volume":"28","author":"Aso","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0240","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/STROKEAHA.108.531079","article-title":"The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men","volume":"40","author":"Arenillas","year":"2009","journal-title":"Stroke"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0245","doi-asserted-by":"crossref","first-page":"1002.e1","DOI":"10.1016\/j.ahj.2008.08.002","article-title":"Platelet reactivity and response to aspirin in subjects with the metabolic syndrome","volume":"156","author":"Vaduganathan","year":"2008","journal-title":"Am Heart J"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0250","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00000441-200503000-00001","article-title":"Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III)","volume":"329","author":"Liangpunsakul","year":"2005","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1111\/j.1477-2574.2011.00380.x_bb0260","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0270","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ajg.2010.299","article-title":"Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial","volume":"106","author":"Foster","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0280","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0285","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","article-title":"Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C","volume":"46","author":"Targher","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0290","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.21171","article-title":"Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States","volume":"43","author":"Ioannou","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0295","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u2018hits\u2019?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","article-title":"Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis","volume":"27","author":"Weltman","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0305","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0320","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2796.1993.tb00640.x","article-title":"Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy","volume":"233","author":"Hultcrantz","year":"1993","journal-title":"J Intern Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0335","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver","volume":"1","author":"Maharaj","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0340","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease. LIDO Study Group","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0345","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cgh.2008.12.015","article-title":"Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease","volume":"7","author":"Vuppalanchi","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0350","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.21346","article-title":"Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease","volume":"44","author":"Merriman","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0355","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SLA.0b013e3181bcd6dd","article-title":"Assessment of hepatic steatosis by expert pathologists: the end of a gold standard","volume":"250","author":"El-Badry","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0360","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jamcollsurg.2007.08.020","article-title":"Preoperative radiographic assessment of hepatic steatosis with histologic correlation","volume":"206","author":"Cho","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0365","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mrm.20825","article-title":"Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy","volume":"55","author":"Machann","year":"2006","journal-title":"Magn Reson Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0370","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00330-007-0801-0","article-title":"Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging","volume":"18","author":"Irwan","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.2003.036566","article-title":"Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study","volume":"54","author":"Thomas","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1148\/radiol.2511080666","article-title":"Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5T","volume":"251","author":"Yokoo","year":"2009","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0385","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1148\/radiol.2501071934","article-title":"Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging","volume":"250","author":"Borra","year":"2009","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0390","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0395","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinimag.2008.06.036","article-title":"Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?","volume":"33","author":"Qayyum","year":"2009","journal-title":"Clin Imaging"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiol.2493080217","article-title":"Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy","volume":"250","author":"Guiu","year":"2009","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0405","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.2491071375","article-title":"Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers","volume":"249","author":"Bahl","year":"2008","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.10091790","article-title":"Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy","volume":"256","author":"van Werven","year":"2010","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0415","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.11101942","article-title":"Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography","volume":"259","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"Park","year":"2006","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0425","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2442061177","article-title":"Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index","volume":"244","author":"Lee","year":"2007","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0430","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000140499.23683.0D","article-title":"Noninvasive evaluation of graft steatosis in living donor liver transplantation","volume":"78","author":"Iwasaki","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0435","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Nonalcoholic Steatohepatitis Clinical Research Network","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0440","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1111\/j.1477-2574.2011.00380.x_bb0445","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0003-4975(98)00967-9","article-title":"Inflammatory response to cardiopulmonary bypass","volume":"66","author":"Edmunds","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0450","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0455","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1245\/s10434-010-1383-7","article-title":"Glasgow prognostic score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer","volume":"18","author":"Vashist","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0460","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/SLA.0b013e3181454171","article-title":"Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer","volume":"246","author":"Ishizuka","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0465","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3324\/haematol.10828","article-title":"Venous thromboembolism\u2013a manifestation of the metabolic syndrome","volume":"92","author":"Ay","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0470","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/ATVBAHA.109.184085","article-title":"Metabolic syndrome is associated with venous thromboembolism in the Korean population","volume":"29","author":"Jang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0475","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2006.02132.x","article-title":"The metabolic syndrome and the risk of venous thrombosis: a case-control study","volume":"4","author":"Ageno","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1111\/j.1477-2574.2011.00380.x_bb0480","first-page":"1536","article-title":"The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation","volume":"23","author":"D'Alessandro","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0485","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/SLA.0b013e31811ea9d2","article-title":"Steatosis as a risk factor in liver surgery","volume":"246","author":"Abdalla","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0490","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00007890-199304000-00024","article-title":"Risk factors for primary dysfunction after liver transplantation\u2013a multivariate analysis","volume":"55","author":"Ploeg","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0495","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2001-12933","article-title":"Fatty liver in liver transplantation and surgery","volume":"21","author":"Selzner","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0500","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.sla.0000225113.88433.cf","article-title":"Steatosis as a risk factor in liver surgery","volume":"245","author":"Vetel\u00e4inen","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0505","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/bjs.6479","article-title":"Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy","volume":"96","author":"Nagai","year":"2009","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0510","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1091-255X(01)00019-1","article-title":"Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer","volume":"6","author":"Little","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0515","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0520","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0525","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/bjc.1998.333","article-title":"Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer","volume":"77","author":"Peppercorn","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0535","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1470-2045(09)70064-6","article-title":"Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases","volume":"10","author":"Chun","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0540","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00534-008-0016-z","article-title":"Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases","volume":"16","author":"Khan","year":"2009","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0545","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0550","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0555","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1200\/JCO.2005.03.2334","article-title":"Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note","volume":"23","author":"Bilchik","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0560","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11894-008-0012-0","article-title":"Nonalcoholic fatty liver disease as a component of the metabolic syndrome","volume":"10","author":"Khashab","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"issue":"9","key":"10.1111\/j.1477-2574.2011.00380.x_bb0565","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2007.06.005","article-title":"Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?","volume":"120","author":"Grundy","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-009-0008-4","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk","volume":"11","author":"Misra","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0575","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. American Heart Association; National Heart, Lung, and Blood Institute","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0580","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0585","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.23521","article-title":"Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?","volume":"51","author":"Angulo","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0590","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0595","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/gut.2003.027581","article-title":"Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life","volume":"53","author":"Hickman","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0600","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1572-0241.2005.41334.x","article-title":"One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study","volume":"100","author":"Huang","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8278(97)80287-5","article-title":"Therapeutic effects of restricted diet and exercise in obese patients with fatty liver","volume":"27","author":"Ueno","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0610","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children","volume":"14","author":"Wang","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0615","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.transproceed.2008.08.045","article-title":"Correlation between hepatic steatosis, hepatic volume, and spleen volume in live liver donors","volume":"40","author":"Chen","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0620","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0625","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0630","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tem.2010.08.003","article-title":"Novel treatment modalities for nonalcoholic steatohepatitis","volume":"21","author":"Satapathy","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0635","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0640","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0645","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. LIDO Study Group","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0650","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0655","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0660","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.1840160426","article-title":"Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis","volume":"16","author":"Parola","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0665","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-5793(92)81290-3","article-title":"Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver","volume":"308","author":"Parola","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0670","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0675","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0680","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1445-5994.2006.01295.x","article-title":"Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study","volume":"37","author":"Yakaryilmaz","year":"2007","journal-title":"Intern Med J"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0685","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.cgh.2006.09.025","article-title":"Swiss Association for the Study of the Liver. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis","volume":"4","author":"Dufour","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0690","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0695","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/SLA.0b013e3181b674df","article-title":"Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry","volume":"250","author":"Kishi","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0700","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archsurg.137.6.675","article-title":"Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization","volume":"137","author":"Abdalla","year":"2002","journal-title":"Arch Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0705","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/bjs.5836","article-title":"Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome","volume":"94","author":"Ribero","year":"2007","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0715","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/000313480407000709","article-title":"Contralateral portal vein embolization for hepatectomy in the setting of hepatic steatosis","volume":"70","author":"Anderson","year":"2004","journal-title":"Am Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0720","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/01.sla.0000098620.27623.7d","article-title":"A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning","volume":"238","author":"Clavien","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0725","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bja\/aeh195","article-title":"Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial","volume":"93","author":"Chouk\u00e8r","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0730","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jamcollsurg.2005.10.021","article-title":"Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study","volume":"202","author":"Azoulay","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0735","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/01.sla.0000246834.07130.5d","article-title":"A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection","volume":"244","author":"Petrowsky","year":"2006","journal-title":"Ann Surg"},{"issue":"1","key":"10.1111\/j.1477-2574.2011.00380.x_bb0740","first-page":"CD007629","article-title":"Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion","author":"Gurusamy","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0745","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/SLA.0b013e31820b4bfc","article-title":"Early postoperative hyperglycemia is associated with postoperative complications after pancreatoduodenectomy","volume":"253","author":"Eshuis","year":"2011","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0750","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SLA.0b013e31818990d1","article-title":"Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery","volume":"248","author":"Ramos","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0755","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhin.2007.12.002","article-title":"Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan","volume":"68","author":"Ambiru","year":"2008","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0760","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0765","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients. NICE-SUGAR Study","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2011.00380.x_bb0770","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ALN.0b013e3181649314","article-title":"Metabolic syndrome and insulin resistance: perioperative considerations","volume":"108","author":"Bagry","year":"2008","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1111\/j.1477-2574.2011.00380.x_bb0775","doi-asserted-by":"crossref","first-page":"i24","DOI":"10.1093\/bja\/aeq293","article-title":"Anaesthetic considerations with the metabolic syndrome","volume":"105","author":"Tung","year":"2010","journal-title":"Br J Anaesth"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15303932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15303932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:54:16Z","timestamp":1761263656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15303932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":154,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1365182X15303932"],"URL":"https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00380.x","relation":{},"ISSN":["1365-182X"],"issn-type":[{"type":"print","value":"1365-182X"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome and hepatic resection: improving outcome","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1477-2574.2011.00380.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}